Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas.
Saved in:
| Title: | Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas. |
|---|---|
| Authors: | Schaefer IM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Lundberg MZ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Demicco EG; Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Przybyl J; Department of Pathology, Stanford University School of Medicine, Stanford, California., Matusiak M; Department of Pathology, Stanford University School of Medicine, Stanford, California., Chibon F; The Institut national de la santé et de la recherche médicale (INSERM) U1037, Cancer Research Center of Toulouse, Department of Pathology, Claudius Régaud Institute, IUCT-Oncopole, Toulouse, France., Ingram DR; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hornick JL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bauer S; Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Duisburg-Essen Medical School, Essen, Germany.; Partner Site Essen and German Cancer Consortium, Heidelberg, Germany., Baker LH; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., van de Rijn M; Department of Pathology, Stanford University School of Medicine, Stanford, California., Mariño-Enríquez A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Fletcher JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. |
| Source: | Cancer [Cancer] 2021 Aug 01; Vol. 127 (15), pp. 2666-2673. Date of Electronic Publication: 2021 Mar 31. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33788262 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schaefer+IM%22">Schaefer IM</searchLink>; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lundberg+MZ%22">Lundberg MZ</searchLink>; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Demicco+EG%22">Demicco EG</searchLink>; Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Przybyl+J%22">Przybyl J</searchLink>; Department of Pathology, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Matusiak+M%22">Matusiak M</searchLink>; Department of Pathology, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Chibon+F%22">Chibon F</searchLink>; The Institut national de la santé et de la recherche médicale (INSERM) U1037, Cancer Research Center of Toulouse, Department of Pathology, Claudius Régaud Institute, IUCT-Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Ingram+DR%22">Ingram DR</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Hornick+JL%22">Hornick JL</searchLink>; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Wang+WL%22">Wang WL</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Bauer+S%22">Bauer S</searchLink>; Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Duisburg-Essen Medical School, Essen, Germany.; Partner Site Essen and German Cancer Consortium, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Baker+LH%22">Baker LH</searchLink>; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Lazar+AJ%22">Lazar AJ</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22van+de+Rijn+M%22">van de Rijn M</searchLink>; Department of Pathology, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Mariño-Enríquez+A%22">Mariño-Enríquez A</searchLink>; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Fletcher+JA%22">Fletcher JA</searchLink>; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2021 Aug 01; Vol. 127 (15), pp. 2666-2673. <i>Date of Electronic Publication: </i>2021 Mar 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33788262 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cncr.33542 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2666 Titles: – TitleFull: Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schaefer IM – PersonEntity: Name: NameFull: Lundberg MZ – PersonEntity: Name: NameFull: Demicco EG – PersonEntity: Name: NameFull: Przybyl J – PersonEntity: Name: NameFull: Matusiak M – PersonEntity: Name: NameFull: Chibon F – PersonEntity: Name: NameFull: Ingram DR – PersonEntity: Name: NameFull: Hornick JL – PersonEntity: Name: NameFull: Wang WL – PersonEntity: Name: NameFull: Bauer S – PersonEntity: Name: NameFull: Baker LH – PersonEntity: Name: NameFull: Lazar AJ – PersonEntity: Name: NameFull: van de Rijn M – PersonEntity: Name: NameFull: Mariño-Enríquez A – PersonEntity: Name: NameFull: Fletcher JA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2021 Aug 01 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1097-0142 Numbering: – Type: volume Value: 127 – Type: issue Value: 15 Titles: – TitleFull: Cancer Type: main |
| ResultId | 1 |